Cargando…

Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer

BACKGROUND: We investigated the prognostic impact of changes in serum CA125 levels during the first 3 months of therapy in ovarian cancer. METHODS: A case series of 170 ovarian cancer patients treated at Cancer Treatment Centers of America. Based on CA125 levels at baseline and 3 months, patients we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Digant, Lammersfeld, Carolyn A, Vashi, Pankaj G, Braun, Donald P
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959041/ https://www.ncbi.nlm.nih.gov/pubmed/20939881 http://dx.doi.org/10.1186/1757-2215-3-22

Ejemplares similares

Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer
por: Vashi, Pankaj G, et al.
Publicado: (2011)

Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology
por: Vashi, Pankaj G, et al.
Publicado: (2010)

Can subjective global assessment of nutritional status predict survival in ovarian cancer?
por: Gupta, Digant, et al.
Publicado: (2008)

Methylmalonic Acid and Homocysteine as Indicators of Vitamin B-12 Deficiency in Cancer
por: Vashi, Pankaj, et al.
Publicado: (2016)

A longitudinal study investigating quality of life and nutritional outcomes in advanced cancer patients receiving home parenteral nutrition
por: Vashi, Pankaj G, et al.
Publicado: (2014)

The Association between Pre-Treatment Serum 25-Hydroxyvitamin D and Survival in Newly Diagnosed Stage IV Prostate Cancer
por: Gupta, Digant, et al.
Publicado: (2015)

The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy
por: Vashi, Pankaj G, et al.
Publicado: (2013)

Role of nutritional status in predicting quality of life outcomes in cancer – a systematic review of the epidemiological literature
por: Lis, Christopher G, et al.
Publicado: (2012)

Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature
por: Gupta, Digant, et al.
Publicado: (2009)

Prevalence, sources, and predictors of soy consumption in breast cancer
por: Lammersfeld, Carolyn A, et al.
Publicado: (2009)

The relationship between bioelectrical impedance phase angle and subjective global assessment in advanced colorectal cancer
por: Gupta, Digant, et al.
Publicado: (2008)

Bioelectrical impedance phase angle as a prognostic indicator in breast cancer
por: Gupta, Digant, et al.
Publicado: (2008)

Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer
por: Gupta, Digant, et al.
Publicado: (2009)

Large Bowel Obstruction following Endoscopic Spray Cryotherapy for Palliation of Rectal Cancer Bleeding
por: Prakash, Ravi, et al.
Publicado: (2017)

Longitudinal health-related quality of life assessment: implications for prognosis in ovarian cancer
por: Gupta, Digant, et al.
Publicado: (2013)

Renal Cell Carcinoma with Unusual Metastasis to the Small Intestine Manifesting as Extensive Polyposis: Successful Management with Intraoperative Therapeutic Endoscopy
por: Vashi, Pankaj G., et al.
Publicado: (2011)

Colon Carcinoma with Unusual Metastasis to the Esophagus Manifesting as Multiple Nodules and Dysphagia: Management with Systemic Chemotherapy
por: Vashi, Pankaj G., et al.
Publicado: (2012)

Safety of endoscopy in cancer patients on antiangiogenic agents: A retrospective multicenter outcomes study
por: Kachaamy, Toufic, et al.
Publicado: (2017)

The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer
por: Vashi, Pankaj G., et al.
Publicado: (2015)

Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer.
por: Rustin, G. J., et al.
Publicado: (1996)

Is CA125 useful in monitoring patients with platinum-resistant ovarian cancer?
por: Rustin, G. J. S., et al.
Publicado: (2016)

A longitudinal analysis with CA-125 to predict overall survival in patients with ovarian cancer
por: Chiang, An Jen, et al.
Publicado: (2014)

Incidence of and factors associated with catheter-related bloodstream infection in patients with advanced solid tumors on home parenteral nutrition managed using a standardized catheter care protocol
por: Vashi, Pankaj G., et al.
Publicado: (2017)

Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer
por: Vashi, Pankaj G., et al.
Publicado: (2019)

Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
por: Tuxen, M K, et al.
Publicado: (2001)

CA125 in ovarian tumour tissue at second laparotomy.
por: Maughan, T. S., et al.
Publicado: (1989)

HE4, CA-125, and cystic ovarian mass
por: Wiwanitkit, Viroj
Publicado: (2012)

CA125 and Ovarian Cancer: A Comprehensive Review
por: Charkhchi, Parsa, et al.
Publicado: (2020)

Salvaging Detection of Early-Stage Ovarian Malignancies When CA125 Is Not Informative
por: Dunton, Charles J., et al.
Publicado: (2021)

Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation
por: Menon, U, et al.
Publicado: (1999)

Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125
por: Weiland, Florian, et al.
Publicado: (2012)

Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2020)

CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.
por: Canney, P. A., et al.
Publicado: (1985)

The Value of CA 125 and CA72-4 in Management of Patients with Epithelial Ovarian Cancer
por: Fayed, Salah T., et al.
Publicado: (1998)

Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.
por: Mogensen, O., et al.
Publicado: (1990)

Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer
por: Tcherkassova, Janneta, et al.
Publicado: (2011)

TB Peritonitis Mistaken for Ovarian Carcinomatosis Based on an Elevated CA-125
por: Boss, Joseph D., et al.
Publicado: (2012)

Exosomal CA125 as A Promising Biomarker for Ovarian Cancer Diagnosis
por: Chen, Zhixiang, et al.
Publicado: (2020)

Combined Preoperative LMR and CA125 for Prognostic Assessment of Ovarian Cancer
por: Tang, Ying, et al.
Publicado: (2020)

VCAM-1 complements CA-125 in detecting recurrent ovarian cancer
por: Song, Jin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fdv17roid195h6k7fvvqeqg9u8